[Severe local cutaneous necrosis during treatment with interferon-alpha and ribavirin for chronic viral hepatitis C].
de Ledinghen
V
V
Brudieux
E
E
Beylot-Barry
M
M
Belleannee
G
G
Doutre
M S
MS
Couzigou
P
P
D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D005260:Female; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D009336:Necrosis; D011994:Recombinant Proteins; D012254:Ribavirin / Q000009:adverse effects*; D012867:Skin / Q000473:pathology*
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D012254:Ribavirin